Drug intelligence / Profile preview

zuogui wan

Development stage
Unknown
Lead developer
Tianjiang Pharmaceutical
Administration
Oral
01

Overview

Zuogui Wan is a classic Traditional Chinese Medicine (TCM) formula primarily used to nourish kidney yin and replenish essence. It is traditionally indicated for symptoms of kidney yin deficiency, including lower back and knee soreness, night sweats, fatigue, and dry mouth. Modern clinical and preclinical research has explored its efficacy in treating renal osteodystrophy, osteoporosis, premature ovarian failure, and neuroinflammatory conditions like multiple sclerosis. Its mechanism involves modulating bone metabolism, inhibiting the MAPK signaling pathway (specifically ERK1/2, p38, and JNK), and attenuating microglial M1 polarization to promote remyelination. The formula is manufactured by companies such as Shanghai Lei Yun Shang Pharmaceutical and is widely used in integrative medicine.

Brand names
Zuogui Wan
Other names
Zuogui PillZuo Gui Wan左归丸
02

Targets

JNK (Mitogen-activated protein kinase kinase kinase family)MAPK3 (Mitogen-activated protein kinase 1)RK (Ribokinase)

Beyond the preview

Go deeper on zuogui wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on zuogui wan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call